PRR15 Is a Novel Diagnostic and Prognostic Biomarker in Papillary Thyroid Cancer and Modulates the Tumor Microenvironment

Lingli Wang, Xiaoqing Deng, Yi Chen, Yixia Zhao, Zhirong Li

Open source

DOI
10.1155/2022/3290479
Published
2022-09-15
Container
Journal of Oncology
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/3290479,
  title = {PRR15 Is a Novel Diagnostic and Prognostic Biomarker in Papillary Thyroid Cancer and Modulates the Tumor Microenvironment},
  author = {Lingli Wang and Xiaoqing Deng and Yi Chen and Yixia Zhao and Zhirong Li},
  year = {2022},
  journal = {Journal of Oncology},
  doi = {10.1155/2022/3290479},
  url = {https://doi.org/10.1155/2022/3290479}
}

RIS

TY  - JOUR
TI  - PRR15 Is a Novel Diagnostic and Prognostic Biomarker in Papillary Thyroid Cancer and Modulates the Tumor Microenvironment
AU  - Lingli Wang
AU  - Xiaoqing Deng
AU  - Yi Chen
AU  - Yixia Zhao
AU  - Zhirong Li
PY  - 2022
JO  - Journal of Oncology
DO  - 10.1155/2022/3290479
UR  - https://doi.org/10.1155/2022/3290479
ER  - 

APA

Wang, L., Deng, X., Chen, Y., Zhao, Y., & Li, Z. (2022). PRR15 Is a Novel Diagnostic and Prognostic Biomarker in Papillary Thyroid Cancer and Modulates the Tumor Microenvironment. Journal of Oncology. https://doi.org/10.1155/2022/3290479

Source records